Pyxis Oncology (PYXS) Institutional Ownership

$4.15
-0.02 (-0.48%)
(As of 05/17/2024 ET)

Institutional Ownership Changes (13F Filings) for Pyxis Oncology (NASDAQ:PYXS)

Current
Institutional Ownership
Percentage
39.09%
Number of
Institutional Buyers
(last 12 months)
18
Total
Institutional Inflows
(last 12 months)
$19.83M
Number of
Institutional Sellers
(last 12 months)
0
Get PYXS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pyxis Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PYXS Institutional Buying and Selling by Quarter

Pyxis Oncology Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024 Ikarian Capital LLC1,662,408$7.08M0.8%N/A2.823%
5/14/2024 StemPoint Capital LP1,794,195$7.64M2.0%N/A3.047%
5/10/2024 Vanguard Group Inc.1,401,425$5.97M0.0%+7.3%2.380%
5/7/2024Susquehanna Fundamental Investments LLC82,447$351K0.0%N/A0.140%
5/7/2024 SG Americas Securities LLC13,809$59K0.0%N/A0.023%
2/20/2024 Cable Car Capital LLC61,606$111K0.1%N/A0.139%
2/14/2024 Vestal Point Capital LP440,000$792K0.1%N/A0.993%
2/12/2024 Decheng Capital LLC326,810$588K0.2%N/A0.737%
1/31/2024 abrdn plc708,303$1.28M0.0%N/A1.598%
11/29/2023Decheng Capital Management III Cayman LLC326,810$650K0.2%N/A0.737%
11/15/2023 Radcliffe Capital Management L.P.53,288$106K0.0%N/A0.120%
11/14/2023 Schulhoff & Co. Inc.22,000$44K0.0%N/A0.050%
11/13/2023 Acadian Asset Management LLC13,233$26K0.0%N/A0.030%
10/23/2023Commonwealth Equity Services LLC12,950$26K0.0%N/A0.033%
8/14/2023 Prelude Capital Management LLC10,352$27K0.0%N/A0.027%
8/11/2023 Harvest Investment Services LLC116,428$298K0.2%+27.9%0.304%
8/11/2023 ExodusPoint Capital Management LP259,561$664K0.0%+270.8%0.679%
8/10/2023 Cetera Investment Advisers18,260$47K0.0%N/A0.048%
7/10/2023 SG Americas Securities LLC20,497$52K0.0%N/A0.054%
5/16/2023 Hhlr Advisors LTD.530,692$2.13M0.0%-30.6%1.435%
5/4/2023 Barclays PLC118,223$474K0.0%-87.5%0.320%
4/27/2023Simplicity Solutions LLC18,110$73K0.0%N/A0.049%
2/15/2023 Tang Capital Management LLC3,470,700$4.65M0.7%+145.9%9.888%
2/9/2023 Citigroup Inc.357,537$479K0.0%+14.5%1.019%
1/12/2023 Marquette Asset Management LLC58,862$79K0.0%N/A0.168%
11/15/2022 Tang Capital Management LLC1,411,569$2.78M0.3%+2.4%4.022%
11/14/2022 RA Capital Management L.P.764,653$1.51M0.0%-19.8%2.179%
8/15/2022 Acuta Capital Partners LLC645,149$1.54M0.9%+222.6%1.966%
8/15/2022 Laurion Capital Management LP3,170,803$7.55M0.1%+159.9%9.662%
5/16/2022 Ghost Tree Capital LLC75,000$303K0.1%-74.6%0.228%
5/13/2022Tekla Capital Management LLC708,303$2.63M0.1%+424.7%2.157%
2/16/2022 Ghost Tree Capital LLC295,000$3.24M1.2%N/A0.900%
2/15/2022 Laurion Capital Management LP1,162,332$12.75M0.1%N/A3.548%
2/15/2022Davidson Kempner Capital Management LP10,000$109K0.0%N/A0.031%
2/14/2022 Citadel Advisors LLC1,521,617$16.48M0.0%N/A4.644%
2/14/2022 Deerfield Management Company L.P. Series C311,754$3.42M0.1%N/A0.952%
2/14/2022 Hhlr Advisors LTD.764,406$8.39M0.1%N/A2.333%
2/14/2022 Perceptive Advisors LLC1,944,114$21.33M0.3%N/A5.934%
2/14/2022 Sandia Investment Management LP10,000$110K0.0%N/A0.031%
2/14/2022 Ghisallo Capital Management LLC30,000$329K0.0%N/A0.092%
The CHIPS Act Motherlode (Ad)

If you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.

Click here to see my #1 investment for 2024.
2/8/2022 Northern Trust Corp89,235$979K0.0%N/A0.272%
2/2/2022 New York State Common Retirement Fund6,277$69K0.0%N/A0.019%
(Data available from 1/1/2016 forward)

PYXS Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PYXS shares?

During the previous two years, 27 institutional investors and hedge funds held shares of Pyxis Oncology. The most heavily invested institutionals were StemPoint Capital LP ($7.64M), Laurion Capital Management LP ($7.55M), Ikarian Capital LLC ($7.08M), Vanguard Group Inc. ($5.97M), Tang Capital Management LLC ($4.65M), Hhlr Advisors LTD. ($2.13M), and Acuta Capital Partners LLC ($1.54M).Learn more on PYXS's institutional investors.

What percentage of Pyxis Oncology stock is owned by institutional investors?

39.09% of Pyxis Oncology stock is owned by institutional investors. Learn more on PYXS's institutional investor holdings.

Which institutional investors have been buying Pyxis Oncology stock?

Of the 24 institutional investors that purchased Pyxis Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Tang Capital Management LLC ($2.09M), Laurion Capital Management LP ($1.95M), StemPoint Capital LP ($1.79M), Ikarian Capital LLC ($1.66M), abrdn plc ($708.30K), Acuta Capital Partners LLC ($445.15K), and Vestal Point Capital LP ($440K).

How much institutional buying is happening at Pyxis Oncology?

Institutional investors have bought a total of 10,486,591 shares in the last 24 months. This purchase volume represents approximately $28.57M in transactions.

Which Pyxis Oncology major shareholders have been selling company stock?

The following institutional investors have sold Pyxis Oncology stock in the last 24 months: Barclays PLC ($829.83K), Hhlr Advisors LTD. ($233.71K), and RA Capital Management L.P. ($188.74K).

How much institutional selling is happening at Pyxis Oncology?

Institutional investors have sold a total of 1,252,282 shares in the last 24 months. This volume of shares sold represents approximately $4.64M in transactions.


This page (NASDAQ:PYXS) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners